The company has stated that ‘this does not affect Mr Brabeck-Letmathe’s ability to carry out his role as chairman of the Nestlé board of directors’, saying he will continue to fully exercise his duties during the treatment period.
Source: Nestlé
© FoodBev Media Ltd 2024